NANOBIOTIX announces first positive Human data showing that NBTXR3 could become a backbone in Immuno-Oncology
NANOBIOTIX ANNOUNCES FIRST POSITIVE HUMAN DATA SHOWING THAT NBTXR3 COULD BECOME A BACKBONE IN IMMUNO-ONCOLOGY Biomarker two-arm study in 26 Soft Tissue Sarcoma patients Data shows a specific, adaptive immune pattern triggered by NBTXR3 treatment …